Publisher's Synopsis
The book deals with the evaluation of high-dose chemotherapy followed by autologous bone marrow or blood stem cell trans- plantation as treatment forHodgkin's disease, non-Hodgkin's lymphoma and multiple myeloma. Alternative salvages strate- gies in this rapidly developing field are reviewed and risk factors associated with clinical outcome of newly diagnosed lymphomas and lymphomas in relapse are evaluated. Several fundamental issues like detection of minimal residual disease inbone marrow and blood, the need for bone marrow purging and preferences of blood stem cells to bone marrow are discussed. The use of hematopoietic growth factors such as GCSF and GMCSF after bone marrow transplantation are described.
